Appraisal of a systematic review using the John Hopkins Nursing Evidence-Based Practice Research Evidence Appraisal Tool.
Practice Question:
Date:
|
Article Number |
Author and Date |
Evidence Type |
Sample, Sample Size, Setting |
Findings That Help Answer the EBP Question |
Observable Measures |
Limitations |
Evidence Level, Quality |
|
1 |
Vuong, K., Uebel, K., Agaliotis, M., Jun, S., Taggart, J., Suchy, S., Liauw, W., Chin, M., Webber, K., & Harris, M. (2020). Assessing suitability for long-term colorectal cancer shared care: a scenario-based qualitative study. BMC Family Practice, 21(1), 1–9. https://doi.org/10.1186/s12875-020-01311-w
Permalink: https://bmcfampract.biomedcentral.com/articles/10.1186/s12875-020-01311-w
Database: CINAHL |
Evidence: Qualitative
Type: Thematic analysis using an inductive approach.
Purpose: Use patient scenarios to explore views on patient suitability for long-term colorectal cancer shared care across the risk spectrum from survivors, general practitioners, and specialists.
Objectives: To discover new concepts and themes as they pertain to suitable matches between patients and providers |
Sample: Colorectal cancer survivors, general practitioners, cancer specialists of both genders and different age groups
Colorectal cancer survivors had completed all treatment
Cancer specialist included oncologists, surgeons, and nurse coordinators with a specialty in colorectal cancer
All general practitioners and specialist had to be active in their medical practice
Sample Size: 25 total participants: 10 Colorectal cancer survivors 6 General Practitioners 9 Specialists
Setting: In the practitioner’s office or in the homes of the selected participants
Data Saturation Explanation: Yes
· N/A |
Importance of practicing difficult/high-stress situations and how simulation can be incorporated
Utilizing simulation post effective treatment
Simulation relieves/reduces anxiety and allows higher levels of confidence in real life situations and settings
This has shown that simulation can be utilized from start to finish across the healthcare continuum
|
Direct examples of survey question results/answers
Examples of the survey questions and answers
Themes and categories provided for information sought to be obtained through the interviews
Utilization of direct quotes from participants |
Sample size was too small
Sample size did not represent those in different locales (rural and remote settings)
Scenarios were used across the risk spectrum instead of prospective real-world clinical data |
Evidence Level: III Quality: A |
|
2 |
Vrinten, C., Gallagher, A., Waller, J., & Marlow, L. (2019). Cancer stigma and cancer screening attendance: a population-based survey in England. BMC Cancer, 19(1), 1–10. https://doi.org/10.1186/s12885-019-5787-x Permalink: https://chamberlain-on-worldcat-org.chamberlainuniversity.idm.oclc.org/oclc/8291738930 Database: EBSCOhost
|
Evidence: Quantitative
Type: Cross-sectional analysis
Purpose: Use home-based interviews to examine the association between cancer stigma and having been screened as recommended versus not
Objectives: Explore the prevalence and socio-demographic patterning of cancer stigma in the general population and the association with cancer screening attendance
|
Sample: Adults 18-70 years of age
Males and females of a small postcode address
Other areas considered were housewife, house with children, and working status
Sample Size: 2048 participants were eligible to participate. They were gathered from random sampling from the Kantar TNS market research agency. They were selected from April and May of 2016
· N/A |
Overall cancer stigma was low but there was variation among the six subdomains
In those six subdomains stigma was high regarding severity of cancer, ability to make financial decisions, policy opposition statements, personal responsibility statements, avoiding someone diagnosed with cancer
Stigma was higher in men and those of different ethnic backgrounds
Higher the stigma, the higher the association was of not being screened as recommended
These measures can be used to help track and reduce cancer stigma over time |
Direct questions from the Cancer Stigma Scale (CASS) were provided
Answers were provided in quantitative reports and then averages were provided
Weighted and unweighted sample characteristics were provided and further unweighted sociodemographic associations using BAME (black, Asian, and minority ethnic) |
Reduced number of items on the CASS scale yielded decreased internal validity
The Attitudes, Behavior and Cancer UK Survey (ABACUS) had no response rate recorded by the market agency
The CASS was only applicable to cancer in general not specific types of cancer and other research has shown that there is greater stigma to other specific types of cancer.
CASS scale being shortened the internal reliability was lowered
Due to this being a cross-sectional study there was not causality between cancer stigma and cancer screening attendance |
Evidence level: III Quality: A |
|
|
|
|
· N/A |
|
|
|
|
|
|
|
|
· N/A |
|
|
|
|
|
|
|
|
· N/A |
|
|
|
|
|
|
|
|
· N/A |
|
|
|
|
|
|
|
|
· N/A |
|
|
|
|
Attach a reference list with full citations of articles reviewed for this Practice question.
Johns Hopkins Nursing Evidence-Based Practice
Appendix G: Individual Evidence Summary Tool
The Johns Hopkins Hospital/ The Johns Hopkins University
1
Directions for Use of the Individual Evidence Summary Tool
Purpose
This form is used to document the results of evidence appraisal in preparation for evidence synthesis. The form provides the EBP team with documentation of the sources of evidence used, the year the evidence was published or otherwise communicated, the information gathered from each evidence source that helps the team answer the EBP question, and the level and quality of each source of evidence.
Article Number
Assign a number to each reviewed source of evidence. This organizes the individual evidence summary and provides an easy way to reference articles.
Author and Date
Indicate the last name of the first author or the evidence source and the publication/communication date. List both author/evidence source and date.
Evidence Type
Indicate the type of evidence reviewed (for example: RCT, meta-analysis, mixed methods, quaLitative, systematic review, case study, narrative literature review).
Sample, Sample Size, and Setting
Provide a quick view of the population, number of participants, and study location.
Findings That Help Answer the EBP Question
Although the reviewer may find many points of interest, list only findings that directly apply to the EBP question.
Observable Measures
QuaNtitative measures or variables are used to answer a research question, test a hypothesis, describe characteristics, or determine the effect, impact, or influence. QuaLitative evidence uses cases, context, opinions, experiences, and thoughts to represent the phenomenon of study.
Limitations
Include information that may or may not be within the text of the article regarding drawbacks of the piece of evidence. The evidence may list limitations, or it may be evident to you, as you review the evidence, that an important point is missed or the sample does not apply to the population of interest.
Evidence Level and Quality
Using information from the individual appraisal tools, transfer the evidence level and quality rating into this column.